SCHEMBL19081717

SCHEMBL19081717

c1ccc2c(c1)ccc1c2oc2ccc3oc4cc(-c5c6ccccc6c(-c6ccc7c(c6)sc6ccccc67)c6ccccc56)ccc4c3c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 10/20 0.36
CYP1B1 Q16678 10/20 0.36
IKBKB O14920 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HPGD P15428 3/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 9/20 0.34
ABCB1 P08183 3/20 0.34
ABCC1 P33527 3/20 0.34
ABCG2 Q9UNQ0 3/20 0.34
KDM4E B2RXH2 2/20 0.34
HSD17B10 Q99714 2/20 0.34
PRKDC P78527 2/20 0.34
ALOX15 P16050 1/20 0.34
HTT P42858 1/20 0.34
PDE5A O76074 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081721 0.88 RAB9A (0.35) CYP1A1CYP1B1IKBKBALDH1A1HPGD
SCHEMBL19081714 0.88 CYP1A1 (0.36) CYP1A1CYP1B1IKBKBALDH1A1HPGD
SCHEMBL19081710 0.88 CYP1A1 (0.36) CYP1A1CYP1B1ALDH1A1HPGDMAPT
SCHEMBL19081711 0.87 CYP1A1 (0.35) CYP1A1CYP1B1IKBKBALDH1A1HPGD
SCHEMBL17931990 0.87 CYP1A1 (0.38) CYP1A1CYP1B1ALDH1A1HPGDMAPT
SCHEMBL17944177 0.86 MAPT (0.41) ALDH1A1HPGDMAPTRAB9ASMN1; SMN2
SCHEMBL19081724 0.86 CYP1A1 (0.34) CYP1A1CYP1B1IKBKBALDH1A1HPGD
SCHEMBL19081466 0.85 CYP1A1 (0.49) CYP1A1CYP1B1ALDH1A1HPGDMAPT
SCHEMBL19081428 0.85 CYP1A1 (0.45) CYP1A1CYP1B1ALDH1A1HPGDMAPT
SCHEMBL19081696 0.85 TDP1 (0.42) CYP1A1CYP1B1ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885IKBKB 3678/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885IKBKB 3678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.